MXR-30413-68122
1 vaccination
3 coded responses
15 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 727 / AR
- Registered
- 2021-06-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-24
Registered in v-safe
-
2021-06-24
Dose 1 — Janssen/Johnson & Johnson
-
2021-06-24
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-06-25
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-06-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-06-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-06-28
- 2021-06-29
- 2021-06-30
- 2021-07-01
- 2021-07-08
-
2021-07-15
Survey response — day 21, single doseMedDRA: Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Rash · Healthcare visit (other): Primacy care docMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-15
Report sent to call center — day 21, single doseGet care from a doctor or other healthcare professional1 call case(s)
-
2021-07-19
Call successfulParticipant prefers to complete VAERS report online
-
2021-07-22
Survey response — day 28, single doseMedDRA: Menstruation delayed, Menstruation irregular — Feeling: GoodFree text: Change in regular menstrual cycle/ delayed periodMedDRA releases: 2024-11 · check-in free text available
- 2021-08-01
- 2021-08-05
-
2021-12-23
Survey response — 6 months, dose 1MedDRA: Abortion spontaneous, Blood glucose increased, Menstruation irregular, Pregnancy, Progesterone increased, Urticaria — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: High blood glucose. High progesterone. Hives. 14-day ovulation starting a few days after covid shot, resulting in pregnancy. Miscarriage at 8 weeks.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-24 | Janssen/Johnson & Johnson | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-15 | Successful 2021-07-19 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — day 21, single dose
Release 9 — day 28, single dose
Symptoms: Change in regular menstrual cycle/ delayed period
Release 10 — 6 months, dose 1
Symptoms: High blood glucose. High progesterone. Hives. 14-day ovulation starting a few days after covid shot, resulting in pregnancy. Miscarriage at 8 weeks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Blood glucose increased | · | · | ✓ |
| SD | Menstruation delayed | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Progesterone increased | · | · | ✓ |
| SD | Rash | ✓ | · | ✓ |
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release